Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

876 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative assessment of immune complex-mediated hypersensitivity reactions with biotherapeutics in the non-human primate: Critical parameters, safety and lessons for future studies.
Kronenberg S, Husar E, Schubert C, Freichel C, Emrich T, Lechmann M, Giusti AM, Regenass F. Kronenberg S, et al. Among authors: schubert c. Regul Toxicol Pharmacol. 2017 Aug;88:125-137. doi: 10.1016/j.yrtph.2017.06.004. Epub 2017 Jun 15. Regul Toxicol Pharmacol. 2017. PMID: 28624430
Zinc: an underappreciated modulatory factor of brain function.
Marger L, Schubert CR, Bertrand D. Marger L, et al. Among authors: schubert cr. Biochem Pharmacol. 2014 Oct 15;91(4):426-35. doi: 10.1016/j.bcp.2014.08.002. Epub 2014 Aug 15. Biochem Pharmacol. 2014. PMID: 25130547 Review.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.
Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Öztürk M, Schroeter CB, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Ruck T. Huntemann N, et al. Among authors: schubert c. J Neurol Neurosurg Psychiatry. 2025 Jan 11:jnnp-2024-334404. doi: 10.1136/jnnp-2024-334404. Online ahead of print. J Neurol Neurosurg Psychiatry. 2025. PMID: 39798960 Free article.
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
Nicolescu M, Häußler V, Paul F, Oertel FC, Schindler P, Strobl JB, Krumbholz M, Hümmert MW, Bütow F, Tkachenko D, Trebst C, Schubert C, Ayzenberg I, Schwake C, Pakeerathan T, Fischer K, Aktas O, Ringelstein M, Kraemer M, Warnke C, Grothe M, Kaste M, Angstwurm K, Kern P, Kleiter I, Rommer P, Winkelmann A, Walter A, Weber MS, Wickel J, Giglhuber K, Then Bergh F, Senel M, Tumani H, Vardakas I, Dawin E, Revie L, Klotz L, Korporal-Kuhnke M, Jarius S, Wildemann B, Gernert JA, Kümpfel T, Engels D, Havla J, Stolowy N, Stellmann JP; Neuromyelitis Optica Study Group (NEMOS). Nicolescu M, et al. Among authors: schubert c. J Neurol. 2024 Dec 21;272(1):86. doi: 10.1007/s00415-024-12803-5. J Neurol. 2024. PMID: 39708205
876 results